For Clinics & Breeders

Veterinary-grade genomics, built for clinical decisions.

Companion Genetics is the first NGS-based cancer tumor profiling provider for cats — plus custom and whole-genome sequencing when a targeted panel isn't enough. Reports are written to translate directly into a treatment plan.

chr8 · PDGFRA · in-frame indelStructural variants like this are invisible to single-marker PCR panels
Products & clinical utility

Panels built around what you'll actually treat.

Targeted sequencing

Feline oncogene panel

A curated panel of oncogenes relevant to feline tumor biology, sequenced by targeted NGS for high-depth, high-confidence variant calls on tumor tissue or FNA samples.

Custom panel

Custom panels & WES

Need a gene set outside our standard panel? We design custom targeted panels or run whole-exome sequencing for novel or suspected mutations.

WGS

Whole-genome sequencing

For research collaborations or complex cases, whole-genome sequencing gives the deepest possible view of an individual animal's genome.

Sample report

Actionable, not just accurate.

Every report is written for the exam room: what was found, what it means, and what it changes about the treatment plan — not a raw variant list.

How it works

From sample to report in a few clear steps.

1

Collect & ship

Submit a tumor tissue or FNA sample using our kit; we coordinate pickup and cold-chain shipping to the sequencing lab.

2

Sequence

Our sequencing partner extracts and reads the tumor's DNA across our feline oncogene panel.

3

Match & interpret

Variants are matched against our growing feline oncogenomics reference to flag diagnostic, prognostic, and therapeutic significance.

4

Report

You receive a clinician report built around next steps, not just a raw variant list.

When to consider this panel

Cases where a genomic answer changes the plan.

SituationExample
Diagnosis is unclear from histology aloneSevere IBD vs. gastrointestinal lymphoma
A common feline cancer, for full informationLymphoma, mammary carcinoma
Owners want every available option exploredBefore committing to a treatment path
Tracking a cancer already in treatmentRecurrence and response monitoring
No clear standard of care existsUncommon tumor type or location
Sample requirements

What we need to run the panel.

Full collection instructions ship with every kit. In general:

  • FNA: several unstained or stained slides, or ≥0.5 mL liquid in a sterile vial
  • Tissue biopsy: FFPE scrolls or unstained slides, with an adjacent H&E slide
  • Bony tumors: non-decalcified sample where possible — contact us to coordinate with your pathology lab
What's in your report

Built for the exam room.

  • Diagnostic, prognostic, and therapeutic biomarkers found
  • Matching targeted therapies, where a mutation has a known drug match
  • Sample quality metrics (tumor content, sequencing depth)
  • Plain-language summary and references

We're completing formal analytical validation now (Phase 1 of our roadmap) and will publish sensitivity, specificity, and reproducibility figures once that's complete.

Lead generation

Request bulk pricing & clinic integration.

Tell us about your practice and caseload, and we'll follow up with pricing, kit logistics, and turnaround times. Breeders and research partners welcome.

  • Bulk kit pricing for high-volume clinics
  • Sample collection & shipping logistics
  • Integration guidance for your existing LIMS or PMS

We typically respond within two business days.

Thanks — your inquiry is in. A member of our clinical team will reach out shortly.